Cargando…

CA-125 is not a useful marker in metastatic breast cancer.

Detalles Bibliográficos
Autores principales:	Seckl, M. J., Rustin, G. J., Coombes, R. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1992
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977992/ https://www.ncbi.nlm.nih.gov/pubmed/1419631

Ejemplares similares

Is CA125 useful in monitoring patients with platinum-resistant ovarian cancer?
por: Rustin, G. J. S., et al.
Publicado: (2016)

Elevated CA125 levels in patients with metastatic breast carcinoma.
por: Perey, L., et al.
Publicado: (1990)

Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer.
por: Rustin, G. J., et al.
Publicado: (1996)

CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.
por: Canney, P. A., et al.
Publicado: (1985)

Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990)

Audit of CA125 Follow-Up After First-Line Therapy for Ovarian Cancer
por: Krell, Daniel, et al.
Publicado: (2017)

Oncological markers CA-125, CA 19-9 and endometriosis
por: Fiala, Ludek, et al.
Publicado: (2018)

Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes
por: Fang, Cheng, et al.
Publicado: (2017)

Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
por: Haglund, C.
Publicado: (1986)

Preoperative serum CA125: a useful marker for surgical management of endometrial cancer
por: Jiang, Tao, et al.
Publicado: (2015)

Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy.
por: Heikinheimo, M., et al.
Publicado: (1990)

Peritoneal trauma releases CA125?
por: Redman, C. W., et al.
Publicado: (1988)

Is an increase in CA 125 in breast cancer patients an indicator of pleural metastases?
por: Jäger, W., et al.
Publicado: (1994)

The effect of CA125 on metastasis of ovarian cancer: old marker new function
por: Yuan, Qin, et al.
Publicado: (2017)

Ca-125: A Useful Marker to Distinguish Pulmonary Tuberculosis from Other Pulmonary Infections
por: Fortún, J, et al.
Publicado: (2009)

Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas
por: Napoli, Niccolò, et al.
Publicado: (2023)

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
por: Tuxen, M K, et al.
Publicado: (2001)

Lung tumour markers in oncology practice: a study of TPA and CA125
por: Buccheri, G, et al.
Publicado: (2002)

Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker.
por: Canney, P. A., et al.
Publicado: (1984)

CA 125 is a better marker to differentiate endometrial cancer and abnormal uterine bleeding
por: Nithin, Kumar U, et al.
Publicado: (2018)

CA125 effects on humoral immunosuppression
por: Kline, J. Bradford, et al.
Publicado: (2017)

Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)

CA 125 half-life in ovarian cancer: a multivariate survival analysis.
por: Yedema, C. A., et al.
Publicado: (1993)

Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer
por: Sinha, Seema Rani, et al.
Publicado: (2022)

CA125 in ovarian tumour tissue at second laparotomy.
por: Maughan, T. S., et al.
Publicado: (1989)

Relationship of tumor marker CA125 and ovarian tumor stem cells: preliminary identification
por: Zhang, Hui, et al.
Publicado: (2015)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden
por: Liu, Liang, et al.
Publicado: (2016)

Role of CA-125 Level as a Marker in the Management of Severe Pre-Eclampsia
por: Balint, Oana, et al.
Publicado: (2022)

The added value of CA125, HE4, and CA72-4 as markers for ovarian endometriosis diagnosis
por: Micu, Romeo, et al.
Publicado: (2023)

Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High-Risk Populations
por: Li, Guangping, et al.
Publicado: (2022)

CA125 and Ovarian Cancer: A Comprehensive Review
por: Charkhchi, Parsa, et al.
Publicado: (2020)

Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2021)

Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker
por: Sánchez Vega, Juan Fernando, et al.
Publicado: (2018)

The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis
por: Tascı, Canturk, et al.
Publicado: (2012)

Rising CA-125 (Cancer Antigen 125) Levels: Cancer Recurrence or a Vaccine Reaction?
por: Parkash, Jasmita, et al.
Publicado: (2023)

Comparison of Ultrasound and Tumor Marker CA125 in Diagnosis of Adnexal Mass Malignancies
por: Behnamfar, Fariba, et al.
Publicado: (2022)

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma.
por: Fisken, J., et al.
Publicado: (1993)

Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2020)

Potential of combination of DCE-MRI and DWI with serum CA125 and CA199 in evaluating effectiveness of neoadjuvant chemotherapy in breast cancer
por: Zhang, Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l3cdhl5o5d6k0hi25f3ml9bms6